Belpointe Asset Management LLC Agios Pharmaceuticals, Inc. Transaction History

Belpointe Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Mar 06, 2019	SELL	$42.73 - $76.53 $492,164 - $881,472	-11,518 Closed	0 $0
Q3 2018 Nov 23, 2018	BUY	$71.67 - $91.95 $825,495 - $1.06 Million	11,518 New	11,518 $888,000
Q1 2018 Aug 06, 2018	SELL	$59.83 - $86.53 $688,045 - $995,095	-11,500 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$52.12 - $72.33 $376,879 - $523,018	-7,231 Reduced 38.6%	11,500 $657,000
Q3 2017 Nov 16, 2017	BUY	$54.89 - $67.12 $1.03 Million - $1.26 Million	18,731	18,731 $1.25 Million

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.44B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.